Showing results (111-120 of 166) with videos related to

Sort By:
Pageof 17
Langenbeck'S Archives of Surgery|May 30, 2023
Feasibility of laparoscopic radical antegrade modular pancreatosplenectomy (RAMPS) as a standard treatment for distal resectable pancreatic cancerShoki Sato, Atsushi Oba, Tomotaka Kato, et al.
Surgery|November 24, 2022
Evaluation of local recurrence after pancreaticoduodenectomy for borderline resectable pancreatic head cancer with neoadjuvant chemotherapy: Can the resection level change after chemotherapy?Kosuke Kobayashi, Yoshihiro Ono, Shoki Sato, et al.
Reproductive Medicine and Biology|April 28, 2018
Difference in mitochondrial gene expression in granulosa cells between recombinant FSH and hMG cycles under in vitro fertilization and transferNatsuho Saito, Yoshiki Yamashita, Yoshihiro Ono, et al.
Annals of Surgical Oncology|November 23, 2024
Strategies for Recurrent Colorectal Liver Metastases Based on Prognostic Factors and Resectability: Potential Benefit of Multidisciplinary TreatmentKosuke Kobayashi, Yosuke Inoue, Atsushi Oba, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|November 20, 2023
Neoadjuvant chemotherapy for borderline resectable colorectal cancer liver metastases: a single-institution retrospective studyYuki Kitano, Yoshihiro Ono, Kosuke Kobayashi, et al.
Cancer Science|November 1, 2011
Direct inhibition of the transforming growth factor-β pathway by protein-bound polysaccharide through inactivation of Smad2 signalingYoshihiro Ono, Tetsu Hayashida, Ayano Konagai, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|February 10, 2023
Diagnosis and management of postpancreatectomy hemorrhage: A single-center experience of consecutive 1,096 pancreatoduodenectomiesKosuke Kobayashi, Yosuke Inoue, Kojiro Omiya, et al.
Annals of Surgical Oncology|June 26, 2023
Prognostic Impact of Tumor Markers (CEA and CA19-9) on Patients with Resectable Colorectal Liver Metastases Stratified by Tumor Number and Size: Potentially Valuable Biologic Markers for Preoperative TreatmentKosuke Kobayashi, Yoshihiro Ono, Yuki Kitano, et al.
Annals of Surgical Oncology|March 16, 2022
Optimizing Indications for Conversion Surgery Based on Analysis of 454 Consecutive Japanese Cases with Unresectable Pancreatic Cancer Who Received Modified FOLFIRINOX or Gemcitabine Plus Nab-paclitaxel: A Single-Center Retrospective StudyYuta Ushida, Yosuke Inoue, Atsushi Oba, et al.
Journal of Biomedical Science|June 26, 2003
A p53 codon 72 polymorphism associated with prostate cancer development and progression in JapaneseKazuhiro Suzuki, Hiroshi Matsui, Nobuaki Ohtake, et al.
Pageof 17